Directory
>
Joshua Rychak
Joshua Rychak
Vice President R&D, Gene Therapy | Poseida Therapeutics, Inc.
California, United States
Joshua Rychak
Summary
Joshua Rychak is a seasoned Vice President for R&D in Gene Therapy at Poseida Therapeutics, where he spearheads innovative gene insertion and genome editing projects using non-viral delivery methods. With extensive experience in both academia and industry, he has a strong background in biomedical engineering, particularly in the areas of molecular imaging and nanotechnology. Joshua has a proven track record of leading cross-functional teams in the development of cutting-edge medical solutions for complex diseases. His academic contributions include mentoring students and serving on dissertation committees, demonstrating his commitment to education and research. He is also a co-founder of Targeson, where he played a pivotal role in transforming research into viable commercial products. Joshua's passion for translating scientific breakthroughs into clinical applications positions him as a leader in the life sciences sector.
Joshua Rychak
Work Experience
Vice President R&D, Gene Therapy at
Poseida Therapeutics, Inc.
February 2023 - Present
Vice President, In Vivo Gene Therapy at
Poseida Therapeutics, Inc.
February 2022 - February 2023
Executive Director Nanotechnology at
Poseida Therapeutics, Inc.
October 2021 - February 2022
Senior Director, Nanotechnology at
Poseida Therapeutics, Inc.
February 2020 - October 2021
Director, Nanotechnology at
Poseida Therapeutics, Inc.
January 2018 - February 2020
Affiliate Professor of Bioengineering at
University of California, San Diego
January 2011 - January 2018
Scientific Consultant at
Jean Cuendet
August 2016 - December 2017
Vice President for Research and Development at
Targeson
January 2008 - January 2016
Postdoctoral Researcher at
Rector & Visitors of The University of Virginia
January 2006 - January 2008
Joshua Rychak
Education
January 2000 - January 2005
January 1996 - January 2000
international School of Islamabad
West SPringfield High School
Frequently Asked Questions about Joshua Rychak
What is Joshua Rychak email address?
Joshua Rychak's primary email address is *******@poseida.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Joshua Rychak work for?
Joshua Rychak is a Vice President R&D, Gene Therapy at Poseida Therapeutics, Inc., a company specializing in Commercial physical research.
Where Joshua Rychak graduated from?
Joshua Rychak holds a degree in Biomedical Engineering from University of Virginia.
How can I directly contact Joshua Rychak?
To contact Joshua Rychak directly, you can use the email address *******@poseida.com. Complete contact information is available upon registration with Muraena.
Who is Joshua Rychak?
Joshua Rychak is a seasoned Vice President for R&D in Gene Therapy at Poseida Therapeutics, where he spearheads innovative gene insertion and genome editing projects using non-viral delivery methods. With extensive experience in both academia and industry, he has a strong background in biomedical engineering, particularly in the areas of molecular imaging and nanotechnology. Joshua has a proven track record of leading cross-functional teams in the development of cutting-edge medical solutions for complex diseases. His academic contributions include mentoring students and serving on dissertation committees, demonstrating his commitment to education and research. He is also a co-founder of Targeson, where he played a pivotal role in transforming research into viable commercial products. Joshua's passion for translating scientific breakthroughs into clinical applications positions him as a leader in the life sciences sector.
Joshua`s contact details
*******@poseida.com
*******@alumni.virginia.edu
Colleagues
Chief Scientific Officer, Gene Therapy
Vice President, Head of Statistical and Data Sciences
General Counsel, Chief Compliance Officer & Corporate Secretary
Vice President, Information Technology
Chief People & Administration Officer
Senior Vice President Regulatory Affairs
Vice President, Cinical Development
Vice President of Immuno-Oncology
VP, Intellectual Property
Executive Chairman